On the Radar…

BiOptix Diagnosics, Inc announced the closing of a $9M Series B round. The round was led by The Russian Corporation for Nanotechnologies (“RUSNANO”) and joined by Boulder Ventures, which led the company’s series A financing, and several private investors. The funds will be used to expand marketing and establish a subsidiary in Russia (BiOptix Nanoprom LLC) to produce the company’s disposable bionanosensors ‐ glass substrates covered with precision metallic and biofunctional nanofilms. The company also plans to enter into R&D partnerships with academic institutions in Russia. Based in Boulder, Colorado, BiOptix markets the ACCOLADE™ system for label free detection for the biomedical and research markets.